Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as
well as in pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical
Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is
read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings.
Articles are indexed by all major biomedical abstracting databases.
Published articles range from pivotal studies exploring new chemical
entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess
drug safety and tolerability in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability,
and biosimilarity; and changes in practice guidelines and standards, are all of interest
for publication. Clinical Therapeutics
also understands the importance of strengthening the body of evidencesurrounding particular agents through the publication of replication
studies, negative trials, and failed trials. Beyond the clinic, we seek reports that examine the real-world implications of therapeutics
such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries,
which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array
of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are
peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and
objectivity using a blind review process.
In addition to feature articles published monthly, each issue of Clinical Therapeutics
features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update
with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited
to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not
selected for the updates will be considered for general publication. https://www.clinicaltherapeutics.com/content/CFPMore2019
TOPIC UPDATE CALENDAR Submit your manuscript at http://www.ees.elsevier.com/clintherhttp://www.ees.elsevier.com/clinther
https://www.mea.elsevierhealth.com/clinical-therapeutics-01492918.html109297Clinical Therapeuticshttps://www.mea.elsevierhealth.com/media/catalog/product/0/1/01492918_14.jpg00USDOutOfStock <IT><B>Clinical Therapeutics</B></IT> provides peer-reviewed, rapid publication of recent developments in drug and other therapies as
well as in pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition <IT><B>Clinical
Therapeutics </B></IT>features updates on specific topics collated by expert Topic Editors. <IT><B>Clinical Therapeutics</B></IT> is
read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings.
Articles are indexed by all major biomedical abstracting databases.
<P>
Published articles range from pivotal studies exploring new chemical
entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess
drug safety and tolerability in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability,
and biosimilarity; and changes in practice guidelines and standards, are all of interest
for publication. <B><IT>Clinical Therapeutics</IT></B>
also understands the importance of strengthening the body of evidencesurrounding particular agents through the publication of replication
studies, negative trials, and failed trials. Beyond the clinic, we seek reports that examine the real-world implications of therapeutics
such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries,
which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array
of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are
peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and
objectivity using a blind review process.
<P>
In addition to feature articles published monthly, each issue of <B><IT>Clinical Therapeutics</IT></B>
features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update
with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited
to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not
selected for the updates will be considered for general publication. <URL><HREF>https://www.clinicaltherapeutics.com/content/CFPMore</HREF><HTXT>2019
TOPIC UPDATE CALENDAR</HTXT></URL> Submit your manuscript at <URL><HREF>http://www.ees.elsevier.com/clinther</HREF><HTXT>http://www.ees.elsevier.com/clinther</HTXT></URL>
USD000149-2918JOURNALELSEVIERIN STOCK0149-2918Volume 41journalsJournalsNoNoNoNoPlease SelectPlease SelectPlease Select